AI assistant
Health Catalyst, Inc. — Director's Dealing 2021
Aug 4, 2021
33681_dirs_2021-08-04_78871ab2-818f-49ef-a2b7-06512d72daca.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Health Catalyst, Inc. (HCAT)
CIK: 0001636422
Period of Report: 2021-08-02
Reporting Person: Llewelyn Linda (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-08-02 | Common Stock | M | 1100.00 | $10.80 | Acquired | 37211.00 | Direct |
| 2021-08-02 | Common Stock | M | 1100.00 | $11.78 | Acquired | 38311.00 | Direct |
| 2021-08-02 | Common Stock | M | 1100.00 | $10.80 | Acquired | 39411.00 | Direct |
| 2021-08-02 | Common Stock | S | 3300.00 | $58.0151 | Disposed | 36111.00 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-08-02 | Stock Option (Right to Buy) | $11.78 | M | 1100.00 | Disposed | 2028-01-24 | Common Stock (1100.00) | Direct |
| 2021-08-02 | Stock Option (Right to Buy) | $10.80 | M | 1100.00 | Disposed | 2028-09-27 | Common Stock (1100.00) | Direct |
| 2021-08-02 | Stock Option (Right to Buy) | $10.80 | M | 1100.00 | Disposed | 2028-09-27 | Common Stock (1100.00) | Direct |
Footnotes
F1: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 9, 2020, in accordance with Rule 10b5-1.
F2: Represents the weighted average sale price of the shares sold ranging from $57.59 to $58.27 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote.
F3: 25% of the 17,954 shares underlying the options vested in an annual installment on January 24, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on January 24, 2022.
F4: 25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022.